$0.02 (7.34%)
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Lei Xu |
| Industry | Advertising Agencies |
| Sector | Communication Services |
| Current Symbol | HAO |
| CUSIP | G4290F126 |
| CIK | 0001954594 |
| Web | https://www.haoximedia.com |
| Phone | 86 10 13311 587976 |
| Currency | USD |
| Employees | 26 |
| Country | CN |
Liquidity
| Debt-to-Equity Ratio | 0.10 |
| Payout Ratio | 0.00 |
| Current Ratio | 3.45 |
| Quick Ratio | 3.45 |
| Cash Ratio | 1.53 |
Sales & Book Value
| Annual Sales | $32.8M |
| Price / Sales | 0.00 |
| Cash Flow | -0.75 |
| Price / Cash Flow | 0.00 |
| Price / Book | 0.08 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $1.32 |
| Trailing P/E Ratio | -2.59 |
| PEG Ratio | 0.01 |
| P/E Growth | 0.01 |
| Net Income | $3.88M |
| Net Margin | -6.50% |
| Pretax Margin | -5.61% |
| Return on Equity | -16.63% |
| Return on Assets | -13.42% |
Financials Score
| AltmanZ Score | 4.83 |
| Piotroski Score | 3.00 |
| Working Capital | 10.88M |
| Total Assets | 20.66M |
| Ebit | -525.28K |
| Market Cap | 21.03K |
| Total Liabilities | 4.7M |
About Haoxi Health Technology Limited (NASDAQ:HAO) Stock
Haoxi Health Technology Limited, operating with its subsidiaries in China, specializes in providing digital marketing services. The company's offerings encompass online short video marketing, which it delivers to advertisers through its network of media partners, alongside custom-designed marketing strategies. These tailored solutions involve the careful planning, creation, distribution, and optimization of online advertisements across various digital platforms, all aimed at helping advertisers attract new customers, drive conversions, and cultivate consumer loyalty. Advertisements are strategically placed on leading online short video and social media platforms, including popular services like Toutiao, Douyin, WeChat, and Sina Weibo. Haoxi primarily serves an advertiser base within the he ... althcare industry. The company was founded in 2018 and is headquartered in Beijing, China.
2026-07-14 06:30:00
BEIJING, July 14, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), a Beijing-headquartered online marketing solutions provider specializing in one-stop digital marketing services for the health and wellness industry, today announced the signing of a strategic cooperation framework agreement with NOVA MEDIA, a technology company with expertise in AI digital humans and generative AI.
2026-07-13 17:00:00
New York, July 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of approximately $4 million for its client Haoxi Health Technology Ltd (NASDAQ: HAO) (the "Company"), a Beijing-headquartered online marketing solution provider in China, specializing in serving healthcare industry advertiser clients.
2026-07-13 17:00:00
New York, July 13, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $4 million for its client Haoxi Health Technology Ltd (NASDAQ: HAO) (the "Company"), a Beijing-headquartered online marketing solution provider in China, specializing in serving healthcare industry advertiser clients.
Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering
2026-07-10 13:15:00
BEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 10,000,000 of the Company's Class A Ordinary Shares, par value $0.32 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.40 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.33 per share.
Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split
2026-05-19 08:30:00
BEIJING, May 19, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ: HAO; “we” or the “Company”), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0025 per share (the “Class A Ordinary Shares”) and Class B ordinary shares, par value $0.0025 per share (the “Class B Ordinary Shares”), at a ratio of 1-for-128.
2026-05-12 17:00:00
New York, May 12, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the "Offering") of $6.
2026-05-12 17:00:00
New York, May 12, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of $6.5 million for its client Haoxi Health Technology Ltd (NASDAQ: HAO)(the “Company”), a Beijing-headquartered technology company engaged in the provision of online marketing solutions for healthcare industry clients, with a focus on short-form video and news feed advertising across major Chinese digital platforms.
Haoxi Health Technology Ltd Announces $6.5 Million Registered Direct Offering
2026-05-11 08:00:00
BEIJING, May 11, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”) today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of approximately $6.5 million of the Company's securities, including 9,000,000 Class A ordinary shares, par value $0.0025 per share (the “Shares”) and 16,999,998 pre-funded warrants, at a purchase price of $0.25 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.0026 per share.
Frequently Asked Questions
What is the current Haoxi Health Technology Limited (HAO) stock price?
Haoxi Health Technology Limited(NASDAQ:HAO) stock price is $0.285 in the last trading session. During the trading session, HAO stock reached the peak price of $285.44 while $0.235 was the lowest point it dropped to. The percentage change in HAO stock occurred in the recent session was 7.34% while the dollar amount for the price change in HAO stock was $0.02.
HAO's industry and sector of operation?
The NASDAQ listed HAO is part of Advertising Agencies industry that operates in the broader Communication Services sector.
Who are the executives of HAO?
Dongxue Li
| Chief Financial Officer
Lei Xu
| Founder, Chief Operating Officer & Director
|
|
|
How many employees does HAO have?
Number of HAO employees currently stands at 26. HAO operates from Tower C, Building 103, Beijing, None 100000, CN.
Link for HAO official website?
Official Website of HAO is: https://www.haoximedia.com
How do I contact HAO?
HAO could be contacted at phone #86 10 13311 587976 and can also be accessed through its website. HAO operates from Tower C, Building 103, Beijing, None 100000, CN.
How many shares of HAO are traded daily?
The average number of HAO shares traded daily for last 3 months was 2.33M.
What is the market cap of HAO currently?
The market value of HAO currently stands at $16.71K with its latest stock price at $0.285